{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T05:11:35Z","timestamp":1739423495972,"version":"3.37.0"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.semarthrit.2024.152511","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T20:30:24Z","timestamp":1720038624000},"page":"152511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mortality risk in patients with anti-MDA5 antibody-positive dermatomyositis: A risk assessment"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4426-4644","authenticated-orcid":false,"given":"Tomoyuki","family":"Kawada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152511_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152231","article-title":"Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review","volume":"62","author":"Xie","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152511_bib0002","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","article-title":"Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease","volume":"53","author":"Gono","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2024.152511_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107530","article-title":"Hypouricemia as a novel predictor of mortality in anti-MDA5 positive dermatomyositis patients with ILD: A retrospective cohort study","volume":"222","author":"Liu","year":"2024","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152511_bib0004","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s10753-022-01661-w","article-title":"Serum uric acid as a diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease","volume":"45","author":"Wang","year":"2022","journal-title":"Inflammation"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:08:57Z","timestamp":1739344137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":4,"alternative-id":["S0049017224001513"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152511","relation":{},"ISSN":["0049-0172"],"issn-type":[{"type":"print","value":"0049-0172"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality risk in patients with anti-MDA5 antibody-positive dermatomyositis: A risk assessment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152511"}}